Connect with us

Hi, what are you looking for?

Real Investment StarReal Investment Star

Investing

Trump-era China sanctions ended by Biden may be revived under new House GOP bill

Top House Republicans are leading a bill to reverse the Biden administration’s decision to lift sanctions on a Chinese entity linked to the persecution of Uyghurs.

The legislation targeting the Ministry of Public Security’s (MPS) Institute of Forensic Science of China was introduced Wednesday by Rep. Andy Ogles, R-Tenn., and is co-led by House China select committee Chairman John Moolenaar, R-Mich., and House GOP Conference Chairwoman Elise Stefanik, R-N.Y.

‘It’s past time for the U.S. to confront the [Chinese Communist Party’s] human rights abusers, and Congress will have to lead in the absence of a strong commander in chief,’ Ogles told Fox News Digital.

He accused China’s authoritarian government of ‘a long and sordid history of human rights abuses.’

‘Joe Biden has unacceptably chosen to reward a Communist Chinese company despite their genocidal crimes and human rights abuses against the Uyghur population and other ethnic minorities. This legislation to relist China’s Institute of Forensic Science on our Entity List will return us to President Trump’s peace through strength strategy and ensure no U.S. technology is benefiting Communist China’s human rights abuses,’ Stefanik said.

The bill has 10 more House GOP co-sponsors and is backed by conservative groups Heritage Action and America First Policy Institute.

The CCP agency was one of nine entities sanctioned by the Trump administration in May 2020.

A press release at the time accused it of being ‘complicit in human rights violations and abuses committed in China’s campaign of repression, mass arbitrary detention, forced labor and high-technology surveillance against Uighurs, ethnic Kazakhs, and other members of Muslim minority groups in the Xinjiang Uighur Autonomous Region (XUAR).’

The sanctions were lifted in November 2023 while the U.S. was working to persuade China to take a more active role in cracking down on the flow of synthetic drugs and fentanyl precursors from within its borders into the U.S.

State Department spokesman Matthew Miller told reporters at the time that the sanctions were ‘a barrier to achieving cooperation’ on the flow of drugs.

‘When we evaluated the issue and looked at all the merits of de-listing the IFS, ultimately we decided that given the steps China was willing to take to cut down on precursor trafficking, it was an appropriate step,’ he said.

This post appeared first on FOX NEWS

Enter Your Information Below To Receive Latest News, And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    ERP or Enterprise Resource Planning solutions help businesses of all sizes manage their daily business operations. First used in the 1990s, ERP systems have...

    Investing

    Democratic Gov. Janet Mills on Wednesday vetoed a bill aimed at prohibiting foreign influence in Maine elections, but voters will get the final say...

    Latest News

    There were several reasons offered in support of the congestion pricing plan that was supposed to go into effect in New York at the...

    Latest News

    House Speaker Mike Johnson (R-La.) on Wednesday appointed Reps. Scott Perry (R-Pa.) and Ronny Jackson (R-Tex.), two Trump loyalists who denied the results of...

    Disclaimer: realinvestmentstar.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 realinvestmentstar.com